1 | authors | 17,824 |
2 | co-authors | 23 |
3 | nanoconjugates | 4 |
4 | pd-rcts | 4 |
5 | tutees | 4 |
6 | xavánte | 4 |
7 | 'promising | 3 |
8 | abs-eis | 3 |
9 | bal-group | 3 |
10 | bodipy-dif-3s | 3 |
11 | cd-rct | 3 |
12 | iatrochemists | 3 |
13 | lsf-diet | 3 |
14 | medication.we | 3 |
15 | tcm-attenders | 3 |
16 | therapy.we | 3 |
17 | 'coach | 2 |
18 | 'degree | 2 |
19 | 'hearing | 2 |
20 | 'trials | 2 |
21 | 7281 | 2 |
22 | authors.we | 2 |
23 | biochromatograms | 2 |
24 | end-station | 2 |
25 | expert-panel | 2 |
26 | hemodiafilter | 2 |
27 | isofunctional | 2 |
28 | jackdaws | 2 |
29 | mn-221-cl-004 | 2 |
30 | mn-221-cl-005 | 2 |
31 | njr | 2 |
32 | quichuas | 2 |
33 | radiokinematically | 2 |
34 | s9916 | 2 |
35 | search.we | 2 |
36 | studies.alton | 2 |
37 | terrestriality | 2 |
38 | tribunal | 2 |
39 | ‘lasso | 2 |
40 | 'definitional | 1 |
41 | 'interventional | 1 |
42 | 'perpetrators | 1 |
43 | 0.10.we | 1 |
44 | 110/233 | 1 |
45 | 15-ketosterol | 1 |
46 | 23,114 | 1 |
47 | 25,060 | 1 |
48 | 3,478 | 1 |
49 | 3,686 | 1 |
50 | 30/04/09.we | 1 |
51 | 47,231 | 1 |
52 | 5738 | 1 |
53 | 6-7-y-olds | 1 |
54 | adrenalitis | 1 |
55 | adthor | 1 |
56 | alleles/genotypes | 1 |
57 | allylbenzenes | 1 |
58 | apteria | 1 |
59 | authers | 1 |
60 | authores | 1 |
61 | base-population | 1 |
62 | bed-syndrome | 1 |
63 | bib-treated | 1 |
64 | biennium | 1 |
65 | biopsy-specimens | 1 |
66 | biotins | 1 |
67 | bladder/dose | 1 |
68 | cabinetry | 1 |
69 | cdna-clone | 1 |
70 | chest/abdomen/pelvis | 1 |
71 | clastogenicity/aneugenicity | 1 |
72 | cmh-fibers | 1 |
73 | cogeners | 1 |
74 | commentator | 1 |
75 | cp+dm-group | 1 |
76 | current/transmission | 1 |
77 | curve-vas | 1 |
78 | cut-off-point | 1 |
79 | diet.we | 1 |
80 | digitalisglycosides | 1 |
81 | endocoprids | 1 |
82 | eyes-and | 1 |
83 | factorswere | 1 |
84 | fibre-optically | 1 |
85 | firstto | 1 |
86 | frailty-sensitive | 1 |
87 | free-run | 1 |
88 | gammadeltatcr | 1 |
89 | geoepidemiology | 1 |
90 | ham-ascores | 1 |
91 | ifnalpha-2a-group | 1 |
92 | inn-patients | 1 |
93 | lnmaes | 1 |
94 | long-coated | 1 |
95 | machine.we | 1 |
96 | mesocotyl | 1 |
97 | meta-analysis.we | 1 |
98 | methoxyflavonoids | 1 |
99 | mid-ninety | 1 |
100 | misdeeds | 1 |
101 | mitotypes | 1 |
102 | mstkg | 1 |
103 | new- | 1 |
104 | persuasions | 1 |
105 | petitioner | 1 |
106 | phanerogams | 1 |
107 | photocarriers | 1 |
108 | picture.we | 1 |
109 | pmr-group | 1 |
110 | pulse-rate | 1 |
111 | purpurogallins | 1 |
112 | questionnairewere | 1 |
113 | radiometrically | 1 |
114 | scaling-approaches | 1 |
115 | self-distraction | 1 |
116 | shaply | 1 |
117 | sn-2-position | 1 |
118 | society.we | 1 |
119 | sovent-electrolytes | 1 |
120 | specificity/accuracy | 1 |
121 | studyand | 1 |
122 | succinimides | 1 |
123 | team.we | 1 |
124 | thermographically | 1 |
125 | trialsand | 1 |
126 | two-teaching-hospitals | 1 |
127 | usa-were | 1 |
128 | wm-test | 1 |
129 | xavix | 1 |
1 | 'coach | 2 |
2 | 'definitional | 1 |
3 | 'degree | 2 |
4 | 'hearing | 2 |
5 | 'interventional | 1 |
6 | 'perpetrators | 1 |
7 | 'promising | 3 |
8 | 'trials | 2 |
9 | 0.10.we | 1 |
10 | 110/233 | 1 |
11 | 15-ketosterol | 1 |
12 | 23,114 | 1 |
13 | 25,060 | 1 |
14 | 3,478 | 1 |
15 | 3,686 | 1 |
16 | 30/04/09.we | 1 |
17 | 47,231 | 1 |
18 | 5738 | 1 |
19 | 6-7-y-olds | 1 |
20 | 7281 | 2 |
21 | abs-eis | 3 |
22 | adrenalitis | 1 |
23 | adthor | 1 |
24 | alleles/genotypes | 1 |
25 | allylbenzenes | 1 |
26 | apteria | 1 |
27 | authers | 1 |
28 | authores | 1 |
29 | authors | 17,824 |
30 | authors.we | 2 |
31 | bal-group | 3 |
32 | base-population | 1 |
33 | bed-syndrome | 1 |
34 | bib-treated | 1 |
35 | biennium | 1 |
36 | biochromatograms | 2 |
37 | biopsy-specimens | 1 |
38 | biotins | 1 |
39 | bladder/dose | 1 |
40 | bodipy-dif-3s | 3 |
41 | cabinetry | 1 |
42 | cd-rct | 3 |
43 | cdna-clone | 1 |
44 | chest/abdomen/pelvis | 1 |
45 | clastogenicity/aneugenicity | 1 |
46 | cmh-fibers | 1 |
47 | co-authors | 23 |
48 | cogeners | 1 |
49 | commentator | 1 |
50 | cp+dm-group | 1 |
51 | current/transmission | 1 |
52 | curve-vas | 1 |
53 | cut-off-point | 1 |
54 | diet.we | 1 |
55 | digitalisglycosides | 1 |
56 | end-station | 2 |
57 | endocoprids | 1 |
58 | expert-panel | 2 |
59 | eyes-and | 1 |
60 | factorswere | 1 |
61 | fibre-optically | 1 |
62 | firstto | 1 |
63 | frailty-sensitive | 1 |
64 | free-run | 1 |
65 | gammadeltatcr | 1 |
66 | geoepidemiology | 1 |
67 | ham-ascores | 1 |
68 | hemodiafilter | 2 |
69 | iatrochemists | 3 |
70 | ifnalpha-2a-group | 1 |
71 | inn-patients | 1 |
72 | isofunctional | 2 |
73 | jackdaws | 2 |
74 | lnmaes | 1 |
75 | long-coated | 1 |
76 | lsf-diet | 3 |
77 | machine.we | 1 |
78 | medication.we | 3 |
79 | mesocotyl | 1 |
80 | meta-analysis.we | 1 |
81 | methoxyflavonoids | 1 |
82 | mid-ninety | 1 |
83 | misdeeds | 1 |
84 | mitotypes | 1 |
85 | mn-221-cl-004 | 2 |
86 | mn-221-cl-005 | 2 |
87 | mstkg | 1 |
88 | nanoconjugates | 4 |
89 | new- | 1 |
90 | njr | 2 |
91 | pd-rcts | 4 |
92 | persuasions | 1 |
93 | petitioner | 1 |
94 | phanerogams | 1 |
95 | photocarriers | 1 |
96 | picture.we | 1 |
97 | pmr-group | 1 |
98 | pulse-rate | 1 |
99 | purpurogallins | 1 |
100 | questionnairewere | 1 |
101 | quichuas | 2 |
102 | radiokinematically | 2 |
103 | radiometrically | 1 |
104 | s9916 | 2 |
105 | scaling-approaches | 1 |
106 | search.we | 2 |
107 | self-distraction | 1 |
108 | shaply | 1 |
109 | sn-2-position | 1 |
110 | society.we | 1 |
111 | sovent-electrolytes | 1 |
112 | specificity/accuracy | 1 |
113 | studies.alton | 2 |
114 | studyand | 1 |
115 | succinimides | 1 |
116 | tcm-attenders | 3 |
117 | team.we | 1 |
118 | terrestriality | 2 |
119 | therapy.we | 3 |
120 | thermographically | 1 |
121 | trialsand | 1 |
122 | tribunal | 2 |
123 | tutees | 4 |
124 | two-teaching-hospitals | 1 |
125 | usa-were | 1 |
126 | wm-test | 1 |
127 | xavix | 1 |
128 | xavánte | 4 |
129 | ‘lasso | 2 |
1 | new- | 1 |
2 | 25,060 | 1 |
3 | 47,231 | 1 |
4 | 7281 | 2 |
5 | 110/233 | 1 |
6 | mn-221-cl-004 | 2 |
7 | 23,114 | 1 |
8 | mn-221-cl-005 | 2 |
9 | s9916 | 2 |
10 | 3,686 | 1 |
11 | 5738 | 1 |
12 | 3,478 | 1 |
13 | apteria | 1 |
14 | bib-treated | 1 |
15 | long-coated | 1 |
16 | eyes-and | 1 |
17 | trialsand | 1 |
18 | studyand | 1 |
19 | 'degree | 2 |
20 | bed-syndrome | 1 |
21 | cdna-clone | 1 |
22 | usa-were | 1 |
23 | questionnairewere | 1 |
24 | factorswere | 1 |
25 | bladder/dose | 1 |
26 | pulse-rate | 1 |
27 | xavánte | 4 |
28 | frailty-sensitive | 1 |
29 | 0.10.we | 1 |
30 | 30/04/09.we | 1 |
31 | machine.we | 1 |
32 | picture.we | 1 |
33 | search.we | 2 |
34 | team.we | 1 |
35 | medication.we | 3 |
36 | meta-analysis.we | 1 |
37 | authors.we | 2 |
38 | diet.we | 1 |
39 | therapy.we | 3 |
40 | society.we | 1 |
41 | mstkg | 1 |
42 | 'hearing | 2 |
43 | 'promising | 3 |
44 | 'coach | 2 |
45 | isofunctional | 2 |
46 | 'definitional | 1 |
47 | 'interventional | 1 |
48 | tribunal | 2 |
49 | expert-panel | 2 |
50 | 15-ketosterol | 1 |
51 | mesocotyl | 1 |
52 | biennium | 1 |
53 | current/transmission | 1 |
54 | base-population | 1 |
55 | end-station | 2 |
56 | self-distraction | 1 |
57 | sn-2-position | 1 |
58 | studies.alton | 2 |
59 | free-run | 1 |
60 | ‘lasso | 2 |
61 | firstto | 1 |
62 | ifnalpha-2a-group | 1 |
63 | bal-group | 3 |
64 | cp+dm-group | 1 |
65 | pmr-group | 1 |
66 | gammadeltatcr | 1 |
67 | petitioner | 1 |
68 | hemodiafilter | 2 |
69 | njr | 2 |
70 | adthor | 1 |
71 | commentator | 1 |
72 | bodipy-dif-3s | 3 |
73 | quichuas | 2 |
74 | curve-vas | 1 |
75 | misdeeds | 1 |
76 | methoxyflavonoids | 1 |
77 | endocoprids | 1 |
78 | 6-7-y-olds | 1 |
79 | lnmaes | 1 |
80 | succinimides | 1 |
81 | digitalisglycosides | 1 |
82 | tutees | 4 |
83 | scaling-approaches | 1 |
84 | allylbenzenes | 1 |
85 | alleles/genotypes | 1 |
86 | mitotypes | 1 |
87 | ham-ascores | 1 |
88 | authores | 1 |
89 | nanoconjugates | 4 |
90 | sovent-electrolytes | 1 |
91 | abs-eis | 3 |
92 | adrenalitis | 1 |
93 | chest/abdomen/pelvis | 1 |
94 | 'trials | 2 |
95 | two-teaching-hospitals | 1 |
96 | phanerogams | 1 |
97 | biochromatograms | 2 |
98 | biopsy-specimens | 1 |
99 | purpurogallins | 1 |
100 | biotins | 1 |
101 | persuasions | 1 |
102 | cmh-fibers | 1 |
103 | tcm-attenders | 3 |
104 | authers | 1 |
105 | photocarriers | 1 |
106 | cogeners | 1 |
107 | authors | 17,824 |
108 | co-authors | 23 |
109 | 'perpetrators | 1 |
110 | pd-rcts | 4 |
111 | inn-patients | 1 |
112 | iatrochemists | 3 |
113 | jackdaws | 2 |
114 | cd-rct | 3 |
115 | lsf-diet | 3 |
116 | cut-off-point | 1 |
117 | wm-test | 1 |
118 | xavix | 1 |
119 | specificity/accuracy | 1 |
120 | geoepidemiology | 1 |
121 | thermographically | 1 |
122 | radiometrically | 1 |
123 | radiokinematically | 2 |
124 | fibre-optically | 1 |
125 | shaply | 1 |
126 | cabinetry | 1 |
127 | mid-ninety | 1 |
128 | clastogenicity/aneugenicity | 1 |
129 | terrestriality | 2 |